MedPath
HSA Approval

DEXTROSE 5% AND SODIUM CHLORIDE 0.9% INJECTION USP

SIN05731P

DEXTROSE 5% AND SODIUM CHLORIDE 0.9% INJECTION USP

DEXTROSE 5% AND SODIUM CHLORIDE 0.9% INJECTION USP

April 8, 1991

BAXTER HEALTHCARE (ASIA) PTE LTD

BAXTER HEALTHCARE (ASIA) PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantBAXTER HEALTHCARE (ASIA) PTE LTD
Licence HolderBAXTER HEALTHCARE (ASIA) PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
General Sale List
HSA Singapore Classification

Formulation Information

INJECTION

INTRAVENOUS

Medical Information

V06DC01

glucose

Manufacturer Information

BAXTER HEALTHCARE (ASIA) PTE LTD

Baxter Healthcare Corporation, North Cove Plant

BAXTER HEALTHCARE PHILIPPINES INC

Active Ingredients

SODIUM CHLORIDE

0.9 g/100 ml

Sodium chloride

DEXTROSE ANHYDROUS 4.5 g/100 ml EQV DEXTROSE HYDROUS

5 g/100 ml

D-glucose

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

DEXTROSE 5% AND SODIUM CHLORIDE 0.9% INJECTION USP - HSA Approval | MedPath